Efficacy of cyclophosphamide in toxic epidermal necrolysis
- 1 November 1991
- journal article
- case report
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 25 (5), 778-786
- https://doi.org/10.1016/s0190-9622(08)80969-3
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal inflamed skin: Modulation by recombinant gamma interferon and tumor necrosis factorJournal of the American Academy of Dermatology, 1989
- Cytotoxic T lymphocyte mediated cytolysisBiochemistry, 1988
- Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.The Journal of Experimental Medicine, 1987
- Acute disseminated epidermal necrosis types 1, 2, and 3: Study of sixty casesJournal of the American Academy of Dermatology, 1985
- Cutaneous immunotorescence study of erythema multiforme: Correlation with light microscopic patterns and etiologic agentsJournal of the American Academy of Dermatology, 1984
- Assembly of two types of tubules with putative cytolytic function by cloned natural killer cellsNature, 1983
- Ultrastructural changes during T-lymphocyte-mediated cytolysisCellular Immunology, 1977
- Skin Changes in Graft-vs-Host DiseaseSouthern Medical Journal, 1976
- GRAFT-VERSUS-HOST DISEASE AND TOXIC EPIDERMAL NECROLYSISThe Lancet, 1973
- GRAFT-VERSUS-HOST REACTION AND TOXIC EPIDERMAL NECROLYSISThe Lancet, 1972